Ensign Peak Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Hold |
17,659
| – | – | ﹤0.01% | 1179 |
|
|
2025
Q1 | $935K | Hold |
17,659
| – | – | ﹤0.01% | 1292 |
|
|
2024
Q4 | $989K | Hold |
17,659
| – | – | ﹤0.01% | 1325 |
|
|
2024
Q3 | $925K | Hold |
17,659
| – | – | ﹤0.01% | 1368 |
|
|
2024
Q2 | $725K | Hold |
17,659
| – | – | ﹤0.01% | 1474 |
|
|
2024
Q1 | $765K | Sell |
17,659
-891
| -5% | -$38.6K | ﹤0.01% | 1485 |
|
|
2023
Q4 | $853K | Hold |
18,550
| – | – | ﹤0.01% | 1471 |
|
|
2023
Q3 | $425K | Buy |
18,550
+2,350
| +15% | +$53.9K | ﹤0.01% | 1633 |
|
|
2023
Q2 | $267K | Buy |
+16,200
| New | +$267K | ﹤0.01% | 1724 |
|
|
2023
Q1 | – | Sell |
-108,562
| Closed | -$3.16M | – | 1785 |
|
|
2022
Q4 | $3.16M | Buy |
108,562
+97,392
| +872% | +$2.84M | 0.01% | 675 |
|
|
2022
Q3 | $274K | Sell |
11,170
-18,175
| -62% | -$446K | ﹤0.01% | 1751 |
|
|
2022
Q2 | $122K | Buy |
29,345
+24,255
| +477% | +$101K | ﹤0.01% | 1923 |
|
|
2022
Q1 | $59K | Hold |
5,090
| – | – | ﹤0.01% | 2104 |
|
|
2021
Q4 | $51K | Buy |
+5,090
| New | +$51K | ﹤0.01% | 2140 |
|
|
2021
Q3 | – | Sell |
-40,891
| Closed | -$801K | – | 1875 |
|
|
2021
Q2 | $801K | Hold |
40,891
| – | – | ﹤0.01% | 1493 |
|
|
2021
Q1 | $870K | Buy |
40,891
+19,718
| +93% | +$420K | ﹤0.01% | 1466 |
|
|
2020
Q4 | $629K | Hold |
21,173
| – | – | ﹤0.01% | 1553 |
|
|
2020
Q3 | $459K | Buy |
+21,173
| New | +$459K | ﹤0.01% | 1551 |
|